One study found that PD-L1 expression was less common in primary NSCLC tumor samples compared with metastases measured both in histologic and cytological cohorts.[31] These data suggest that assessing PD-L1 expression in freshly collected tissue and from metastatic sites before treatment with anti-PD-1/PD-L1 agents is important. The gene discussed is CD274; the disease is neoplasm.